Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
Choriocarcinoma is traditionally described as being composed of cytotrophoblast and syncytiotrophoblast. Microscopically, these 2 types of cells are intimately associated with each other, forming a characteristic biphasic plexiform pattern, however, the nature of these 2 types of trophoblastic cells is not well understood. In this study, we used immunohistochemistry for several trophoblastic markers to analyze the trophoblastic subpopulations in 36 gestational choriocarcinomas. Eighty-one specimens including placenta, complete mole, placental site nodule, epithelioid trophoblastic tumor, and placental site trophoblastic tumor were analyzed. The antibodies included Mel-CAM, HLA-G, MUC-4, and beta-catenin. A semiquantitative assessment of positive cells and the cellular localization of these markers were recorded. We found diffuse strong membranous and cytoplasmic staining for MUC-4 in mononucleate cells in all 36 cases (100%) and a similar pattern of localization in 28 cases (78%) for HLA-G. This distribution was similar to that in normal placentas, where MUC-4 and HLA-G are expressed in the trophoblastic cells of the trophoblastic columns and implantation site. In choriocarcinoma, mononucleate trophoblastic cells showed moderate immunoreactivity for Mel-CAM, a specific marker for implantation site intermediate trophoblast, in 78% of the cases. The MUC-4, HLA-G, and Mel-CAM-positive trophoblastic cells were larger than cytotrophoblastic cells, with more abundant cytoplasm, consistent with the morphology of intermediate trophoblast. In contrast, 31% of the choriocarcinomas contained a very small proportion (<5%) of mononucleate trophoblastic cells compatible with cytotrophoblast that was positive for nuclear beta-catenin, a cytotrophoblast-associated marker. These results suggest that choriocarcinoma is composed predominantly of a mixture of syncytiotrophoblast and intermediate trophoblast with only a small proportion of cytotrophoblast. The presence of nuclear beta-catenin staining in the cytotrophoblast of choriocarcinoma is consistent with the view that choriocarcinoma develops from transformed cytotrophoblastic cells which are presumably the cancer stem cells that differentiate into either intermediate trophoblast or syncytiotrophoblast.
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.
Tsui-Lien
TL
Mao
Robert J
RJ
Kurman
Chao-Cheng
CC
Huang
Ming-Chieh
MC
Lin
Ie-Ming
IeM
Shih
D014408:Biomarkers, Tumor / Q000032:analysis*; D051929:CD146 Antigen / Q000032:analysis; D002454:Cell Differentiation; D002467:Cell Nucleus / Q000737:chemistry; D048429:Cell Size; D002822:Choriocarcinoma / Q000737:chemistry / Q000175:diagnosis* / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006680:HLA Antigens / Q000032:analysis; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D008396:Maryland; D055264:Mucin-4; D009077:Mucins / Q000032:analysis; D011247:Pregnancy; D013624:Taiwan; D018245:Trophoblastic Tumor, Placental Site / Q000737:chemistry / Q000175:diagnosis* / Q000473:pathology; D014327:Trophoblasts / Q000737:chemistry* / Q000473:pathology; D014594:Uterine Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000473:pathology; D051176:beta Catenin / Q000032:analysis
D014408:Biomarkers, Tumor; D051929:CD146 Antigen; C495270:CTNNB1 protein, human; D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; C497902:MCAM protein, human; C524658:MUC4 protein, human; D055264:Mucin-4; D009077:Mucins; D051176:beta Catenin